ND PHARMA & BIOTECH PIPELINE
ND 300-SERIES (MEDICAL CONDITIONS)
ND 500-SERIES (FOOD & NUTRITION)
Our R+D+i Philosophy.
We vigorously invest in research, development and innovation to discover and develop new products and eventually, new treatments that meet the needs of specialty doctors and their patients. Our company try to develop world-class research + development + innovation (R&D) programs that embodies our efforts to bring the best of science to medicine and therefore to life, including some new developments within the nutrition science, food, feed and certain industrial sectors. Scientists and researchers work closely with specialists within their respective areas, to transform novel compounds into new therapeutics and products that help improve quality of life. This philosophy is consistent with our motto; Making Life Bette
Our commitment to R&D has been evident since our inception, when we began pioneering new treatments to help preserve certain organic and body functions including neurological functions as memory and cognoscitive abilities. Since then, our investment in R&D+i has progressively increased to a level that is considered best in class for the industry, and we have followed our products into new specialty areas. Our R&D+i programs today are focused in many areas ranging from diabetes and nutrition to surgical innovations. Currently, we are investigating a rich arsenal of potential new treatments for chronic migraine, debilitating neurological conditions, eye disease, and stem cell transplantation, among other conditions and fields. Significant progress in these areas is expected to be made over the next decade - advances in which we look forward playing a prominent role.
Since founding, our company retains the ability to listen and to learn - from our customers, and from each other - has been a cornerstone of our success. ND Pharma & Biotech´s R&D+i culture reflects this, providing an open forum for our and other scientists to share ideas, collaborate on projects, and gain access to the latest research. Access to world-class technology combined with intellectual stimulation results in a dynamic environment where scientists are excited about the work they do and committed to pushing the boundaries of what is possible.
Our R&D+i organization is structured into integrated teams that focus on discovery for different targets. This unique architecture affords many benefits. Scientists normally confined to specific tracks have the opportunity to be involved in the full life-cycle of development, from early-stage exploration to human testing, for a much broader perspective. Additionally, meticulous research is streamlined with highly efficient project and information management, which can save years and millions of dollars from the overall cost of drug development.
Most of our discovery and development programs are initiated internally, which sets us apart from many other health care companies. Simultaneously, we explore new market opportunities and search for partnerships to develop superior technologies that are complementary to our own business model.
In short, at our company, there will be only one way in which we view the purpose of science and innovation - to identify those needs in health care and certain industrial sectors that are unsolved and commit to finding solutions through a meaningful R&D+i investment that fuels future growth. This is our unwavering commitment.
Our Commitment with/for Excellence in Research & Development.
For every new treatment/product that comes to market, hundreds of important discoveries are made along the way that contribute to science, medicine, health and technology. For these contributions and many others, ND Pharma & Biotech provides several opportunities for our scientists to be recognized and rewarded for excellent work in their respective fields and broadly.
Research at our company is ongoing, and with some of the best talent in the health care industry, our scientists regularly publish key findings in peer-reviewed medical journals and other scientific publications both indexed or not. Company also attends key medical and industry meetings throughout the year, where our scientists present their published findings and research in front of their peers.
We are grateful to those members on and related to any of our teams who have demonstrated their commitment to science, technology, healthcare and medicine. Their commitment, intellect, and innovative thinking have the power to advance clinical discoveries and product development and improve the way we and our beloved ones are living.
Our scientists, team leader and project managers are selected and distinguished members of different well-known, well-reputed scientific, medical and research organizations, professional bodies and institutions, maintaining membership and good standing with all relevant societies and up-to-date information, tools and means.
Our commitment to R&D has been evident since our inception, when we began pioneering new treatments to help preserve certain organic and body functions including neurological functions as memory and cognoscitive abilities. Since then, our investment in R&D+i has progressively increased to a level that is considered best in class for the industry, and we have followed our products into new specialty areas. Our R&D+i programs today are focused in many areas ranging from diabetes and nutrition to surgical innovations. Currently, we are investigating a rich arsenal of potential new treatments for chronic migraine, debilitating neurological conditions, eye disease, and stem cell transplantation, among other conditions and fields. Significant progress in these areas is expected to be made over the next decade - advances in which we look forward playing a prominent role.
Since founding, our company retains the ability to listen and to learn - from our customers, and from each other - has been a cornerstone of our success. ND Pharma & Biotech´s R&D+i culture reflects this, providing an open forum for our and other scientists to share ideas, collaborate on projects, and gain access to the latest research. Access to world-class technology combined with intellectual stimulation results in a dynamic environment where scientists are excited about the work they do and committed to pushing the boundaries of what is possible.
Our R&D+i organization is structured into integrated teams that focus on discovery for different targets. This unique architecture affords many benefits. Scientists normally confined to specific tracks have the opportunity to be involved in the full life-cycle of development, from early-stage exploration to human testing, for a much broader perspective. Additionally, meticulous research is streamlined with highly efficient project and information management, which can save years and millions of dollars from the overall cost of drug development.
Most of our discovery and development programs are initiated internally, which sets us apart from many other health care companies. Simultaneously, we explore new market opportunities and search for partnerships to develop superior technologies that are complementary to our own business model.
In short, at our company, there will be only one way in which we view the purpose of science and innovation - to identify those needs in health care and certain industrial sectors that are unsolved and commit to finding solutions through a meaningful R&D+i investment that fuels future growth. This is our unwavering commitment.
Our Commitment with/for Excellence in Research & Development.
For every new treatment/product that comes to market, hundreds of important discoveries are made along the way that contribute to science, medicine, health and technology. For these contributions and many others, ND Pharma & Biotech provides several opportunities for our scientists to be recognized and rewarded for excellent work in their respective fields and broadly.
Research at our company is ongoing, and with some of the best talent in the health care industry, our scientists regularly publish key findings in peer-reviewed medical journals and other scientific publications both indexed or not. Company also attends key medical and industry meetings throughout the year, where our scientists present their published findings and research in front of their peers.
We are grateful to those members on and related to any of our teams who have demonstrated their commitment to science, technology, healthcare and medicine. Their commitment, intellect, and innovative thinking have the power to advance clinical discoveries and product development and improve the way we and our beloved ones are living.
Our scientists, team leader and project managers are selected and distinguished members of different well-known, well-reputed scientific, medical and research organizations, professional bodies and institutions, maintaining membership and good standing with all relevant societies and up-to-date information, tools and means.
